Business Wire

SES-S.A.

30.4.2024 07:31:31 CEST | Business Wire | Press release

Share
SES Q1 2024 Results

SES S.A. announces financial results for the three months ended 31 March 2024 and a solid start to the 2024 financial year.

  • Revenue of €498 million (+2.5% YOY(1)) and Adjusted EBITDA(2) of €275 million (+4.7% YOY)
  • Networks up 9.6% YOY(1) including periodic revenue, with Video performance (-5.2% YOY(1)) in line with expectations
  • More than €125 million of new business and contract renewals signed in Q1 2024
  • Adjusted Free Cash Flow of €38 million net inflow compared with €(41) million net outflow in Q1 2023
  • Net Leverage at 1.5x(3) including cash & cash equivalents of €2.4 billion
  • Landmark quarter with 2nd generation MEO constellation, O3b mPOWER, beginning customer services in April 2024
  • €220 million dividend payment (€0.50 per A-share) made to shareholders in April, complemented by on-going share buyback of up to €150 million and interim dividend of €110 million dividend payment (€0.25 per A-share) to be paid in October 2024
  • Outlook(4) for FY 2024 Revenue, Adjusted EBITDA, and capital expenditure on track and re-affirmed

Adel Al-Saleh, CEO of SES, commented: “The first quarter results demonstrate our solid start to the year, and we continued to deliver commercial momentum across the business, underpinning our FY 2024 financial outlook which is on track and unchanged.

Our Networks business now accounts for over 50% of revenue and delivered YOY growth including periodic revenue from a contract modification which allowed us to recontract capacity on our highly contended MEO fleet and generate incremental cash flows. In Video, our Sports & Events offering continued to be the standout performer, adding to its impressive line-up of customers with an exciting new agreement with a global tier one sports brand to distribute live content to audiences across the world.

April 2024 delivered a landmark milestone for SES with the entry into commercial service of O3b mPOWER, our next generation MEO constellation, strengthening our capability to deliver competitive and differentiated customer solutions in valuable, high growth government, mobility, and fixed data markets. The next O3b mPOWER satellites (7-8) are on track be launched in late 2024 launch and bring improved resiliency to the network which will be further expanded with the launch of satellites 9-11 plus 12 & 13 in 2025 and late 2026 respectively.”

Key business and financial highlights (at constant FX unless explained otherwise)

SES regularly uses Alternative Performance Measures (APM) to present the performance of the group and believes that these APMs are relevant to enhance understanding of the financial performance and financial position.

€ million

Q1 2024

Q1 2023

 

∆ as reported

∆ at constant FX

Average €/$ FX rate

1.09

1.07

 

 

Revenue

498

490

+1.5%

+2.5%

Adjusted EBITDA

275

265

+3.8%

+4.7%

Adjusted Net Profit

77

64

+20.0%

n/m

Adjusted Net Debt / Adjusted EBITDA

1.5x

3.6x

n/m

n/m

“At constant FX” refers to comparative figures restated at the current period FX, to neutralise currency variations.

Networks (54% of total revenues) revenue of €268 million increased 9.6% year on year driven by growth in Mobility (+24.5% including periodic revenue) and Government (+6.1%). Fixed Data revenue (-0.5% year on year) was in line with Q1 2023 as new revenue added was offset by the impact of periodic revenue recognised in the prior period.

Video (46% of total revenues) revenue of €228 million represented a reduction of 5.2% compared with Q1 2023, mainly driven by lower revenue in mature markets which were partially offset by expansion in Sports & Events revenue.

Adjusted EBITDA of €275 million represented an Adjusted EBITDA margin of 55% (Q1 2023: 54%). Adjusted EBITDA excludes significant special items of €6 million (Q1 2023: €13 million), comprising net U.S. C-band expenses of €1 million (Q1 2023: net expenses of €4 million) and expense of other significant special items of €5 million (Q1 2023: €9 million).

Adjusted Net Profit of €77 million was €13 million, or 20.0%, higher than Q1 2023 mainly reflecting the higher year on year Adjusted EBITDA and net interest income of €6 million (Q1 2023: net interest expense of €23 million) which included the benefit of earning interest income on the group’s balance of cash & cash equivalents.

Adjusted Net Debt to Adjusted EBITDA ratio (including 50% of €625 million of hybrid bond as debt) on 31 March 2024 was 1.5 times, (31 March 2023: 3.6 times, 31 December 2023: 1.5 times) including cash & cash equivalents of €2,403 million. In January 2024, SES called and repaid the €550 million hybrid bond and expects to repay approximately €450 million of additional upcoming debt maturities.

The total amount of remaining U.S. C-band clearing cost reimbursements expected to be received in future is now approximately $480 million and SES is continuing to engage with insurers regarding the claim of $472 million relating to O3b mPOWER satellites 1-4.

Contract backlog on 31 March 2024 was €4.0 billion (€5.0 billion gross backlog including backlog with contractual break clauses).

The Full Year 2023 dividend of €0.50 per A-share and €0.20 per B-share was paid to shareholders on 18 April 2024. For Full Year 2024, SES will move to a semi-annual distribution with an interim dividend of €0.25 per A-share (€0.10 per B-share) to be paid in October 2024 and final dividend, subject to shareholder approval, of at least €0.25 per A-share (€0.10 per B-share) to be paid in April 2025.

The share buyback programme of up to €150 million was started in November 2023 and is being executed under the authorisation given by the Annual General Meeting of shareholders held on 6 April 2023. On 31 March 2024, 9 million A-shares had been purchased at an average price of approximately €5.70 per A-share. The aggregate value of the programme shall not exceed €150 million, and the shares acquired are intended to be cancelled, reducing the total number of voting and economic shares in issue.

For Full Year 2024, group revenue and Adjusted EBITDA (assuming an FX rate of €1=$1.09, nominal satellite health, and nominal launch schedule) are expected to be in the range of €1,940-2,000 million and €950-1,000 million respectively, with growth in Networks revenue expected to mostly offset lower year-on-year Video revenue.

Capital expenditure (net cash absorbed by investing activities excluding acquisitions, financial investments, U.S. C-band repurposing, and assuming an FX rate of €1=$1.09) is expected to be in the range of €500-550 million in 2024 with an average annual capital expenditure of approximately €350 million for the period 2025-2028.

Operational performance

REVENUE BY BUSINESS UNIT

 

 

Q1 2024

Revenue (€ million) as reported

Change (YOY) at constant FX

Average €/$ FX rate

1.09

 

Video

228

-5.2%

 

 

 

Networks

268

+9.6%

Government

125

+6.1%

Fixed Data

59

-0.5%

Mobility

84

+24.5%

Other

2

n/m

Group Total

498

+2.5%

“At constant FX” refers to comparative figures restated at the current period FX, to neutralise currency variations.

Future satellite launches

Satellite

Region

Application

Launch Date

ASTRA 1P

Europe

Video

Summer 2024

O3b mPOWER (satellites 7-8)

Global

Fixed Data, Mobility, Government

Late 2024

O3b mPOWER (satellites 9-11)

Global

Fixed Data, Mobility, Government

2025

ASTRA 1Q

Europe

Video, Fixed Data, Mobility, Government

2026

SES-26

Africa, Asia, Europe, Middle East

Video, Fixed Data, Mobility, Government

2026

EAGLE-1

Europe

Government

2026

O3b mPOWER (satellites 12-13)

Global

Fixed Data, Mobility, Government

2026

Final launch dates are subject to confirmation by launch providers.

CONSOLIDATED INCOME STATEMENT

€ million

Q1 2024

Q1 2023

Average €/$ FX rate

1.09

1.07

Revenue

498

490

U.S. C-band repurposing income

1

2

Operating expenses

(230)

(240)

EBITDA

269

252

Depreciation expense

(139)

(148)

Amortisation expense

(19)

(17)

Operating profit

111

87

Net financing income/(costs)

5

(29)

(Loss) / profit before tax

116

58

Income tax expense

(43)

(3)

Net Profit attributable to owners of the parent

73

55

 

 

 

Basic and diluted loss per A-share (in €)(1)

0.16

0.10

Basic and diluted loss per B-share (in €)(1)

0.06

0.04

1) Earnings per share is calculated as profit attributable to owners of the parent divided by the weighted average number of shares outstanding during the year, as adjusted to reflect the economic rights of each class of share. For the purposes of the EPS calculation only, the net profit for the year attributable to ordinary shareholders has been adjusted to include the assumed coupon, net of tax, on the perpetual bonds.

€ million

Q1 2024

Q1 2023

Adjusted EBITDA

275

265

U.S. C-band income

1

2

U.S. C-band operating expenses

(2)

(6)

Other significant special items

(5)

(9)

EBITDA

269

252

€ million

Q1 2024

Q1 2023

Adjusted Net Profit

77

64

U.S. C-band income

1

2

U.S. C-band operating expenses

(2)

(6)

Other significant special items

(5)

(9)

Tax on significant special items

2

4

Net profit attributable to owners of the parent

73

55

SUPPLEMENTARY INFORMATION

QUARTERLY INCOME STATEMENT (AS REPORTED)

€ million

Q1 2023

Q2 2023

Q3 2023

Q4 2023

Q1 2024

Average €/$ FX rate

1.07

1.08

1.08

1.07

1.09

Revenue

490

497

507

536

498

U.S. C-band income

2

1

2,715

26

1

Other income

-

-

-

5

-

Operating expenses

(240)

(251)

(251)

(355)

(230)

EBITDA

252

247

2,971

212

269

Depreciation expense

(148)

(146)

(153)

(156)

(139)

Amortisation expense

(17)

(29)

(21)

(22)

(19)

Non-cash impairment

-

-

(1,553)

(2,123)

-

Operating profit / (loss)

87

72

1,244

(2,089)

111

Net financing income / (costs)

(29)

(18)

(2)

7

5

Profit/ (loss) before tax

58

54

1,242

(2,082)

116

Income tax (expense) / benefit

(3)

(17)

(472)

316

(43)

Non-controlling interests

-

-

-

(1)

-

Net profit/ (loss)

55

37

770

(1,767)

73

 

 

 

 

 

 

Basic earnings / (loss) per share (in €) (1)

 

 

 

 

 

Class A shares

0.10

0.07

1.73

(4.04)

0.16

Class B shares

0.04

0.03

0.69

(1.62)

0.06

 

 

 

 

 

 

Adjusted EBITDA

265

265

262

233

275

Adjusted EBITDA margin

54%

53%

52%

44%

55%

U.S. C-band income

2

1

2,715

26

1

Other income

-

-

-

5

-

U.S. C-band operating expenses

(6)

(7)

(4)

(30)

(2)

Other significant special items

(9)

(12)

(2)

(22)

(5)

EBITDA

252

247

2,971

212

269

1) Earnings per share is calculated as profit attributable to owners of the parent divided by the weighted average number of shares outstanding during the year, as adjusted to reflect the economic rights of each class of share. For the purposes of the EPS calculation only, the net profit for the year attributable to ordinary shareholders has been adjusted to include the coupon, net of tax, on the perpetual bonds. Fully diluted earnings per share are not significantly different from basic earnings per share.

ALTERNATIVE PERFORMANCE MEASURES

SES regularly uses Alternative Performance Measures (‘APM’) to present the performance of the group and believes that these APMs are relevant to enhance understanding of the financial performance and financial position. These measures may not be comparable to similarly titled measures used by other companies and are not measurements under IFRS or any other body of generally accepted accounting principles, and thus should not be considered substitutes for the information contained in the group’s financial statements.

Alternative Performance Measure

Definition

Reported EBITDA and EBITDA margin

EBITDA is profit for the period before depreciation, amortisation, net financing cost, and income tax. EBITDA margin is EBITDA divided by revenue.

Adjusted EBITDA and Adjusted EBITDA margin

EBITDA adjusted to exclude significant special items of a non-recurring nature. The primary exceptional items are the net impact of the repurposing of U.S. C-band spectrum, restructuring charges, costs associated with the development and/or implementation of merger and acquisition activities, specific business taxes, one-off regulatory charges arising outside ongoing operations. Adjusted EBITDA margin is Adjusted EBITDA divided by revenue.

Adjusted Free Cash Flow

Net cash generated by operating activities less net cash absorbed by investing activities, interest paid on borrowings, coupon paid on perpetual bond and lease payments, and adjusted to exclude the effect of cash flows generated by significant special items of a non-recurring nature. The primary exceptional items are the net impact of the repurposing of U.S. C-band spectrum, restructuring charges, costs associated with the development and/or implementation of merger and acquisition activities, specific business taxes, one-off regulatory charges arising outside ongoing operations.

Adjusted Net Debt to Adjusted EBITDA

Adjusted Net Debt to Adjusted EBITDA represents the ratio of Net Debt plus 50% of the group’s hybrid bonds (per the rating agency methodology) divided by the last 12 months’ (rolling) Adjusted EBITDA.

Adjusted Net Profit

Net profit attributable to owners of the parent adjusted to exclude the after-tax impact of significant special items.

Presentation of Results:

A presentation of the results for investors and analysts will be hosted at 9.30 CET on 30 April 2024 and will be broadcast via webcast and conference call. The details for the conference call and webcast are as follows:

U.K.

+44 (0) 33 0551 0200

France

+33 (0) 1 70 37 71 66

Germany

+49 (0) 30 3001 90612

U.S.A.

+1 786 697 3501

 

 

Confirmation code

SES

 

 

Webcast registration

https://channel.royalcast.com/landingpage/ses/20240430_2/

The presentation is available for download from https://www.ses.com/investors/financial-results and a replay will be available shortly after the conclusion of the presentation.

Follow us on:
Twitter | Facebook | YouTube | LinkedIn | Instagram
Read our Blogs >
Visit the Media Gallery >

About SES

SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless data connectivity services around the world. As a leader in global content connectivity solutions, SES owns and operates the world’s only geosynchronous orbit and medium earth orbit (GEO-MEO) constellation of satellites with the unique combination of global coverage and high performance. By leveraging its vast and intelligent, cloud-enabled network, SES delivers high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to the world’s leading telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners. SES’s video network carries over 6,400 channels, reaching 363 million households, delivering managed media services for both linear and non-linear content. The company is headquartered in Luxembourg and listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com.

Disclaimer

This presentation does not, in any jurisdiction, including without limitation in the U.S., constitute or form part of, and should not be construed as, any offer for sale of, or solicitation of any offer to buy, or any investment advice in connection with, any securities of SES, nor should it or any part of it form the basis of, or be relied on in connection with, any contract or commitment whatsoever.​

No representation or warranty, express or implied, is or will be made by SES, its directors, officers or advisors, or any other person, as to the accuracy, completeness or fairness of the information or opinions contained in this presentation, and any reliance you place on them will be at your sole risk. Without prejudice to the foregoing, none of SES, or its directors, officers or advisors accept any liability whatsoever for any loss however arising, directly or indirectly, from use of this presentation or its contents or otherwise arising in connection therewith.​

This presentation includes “forward-looking statements”. All statements other than statements of historical fact included in this presentation, including without limitation those regarding SES’s financial position, business strategy, plans and objectives of management for future operations (including development plans and objectives relating to SES products and services), are forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results, performance, or achievements of SES to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding SES and its subsidiaries and affiliates, present and future business strategies, and the environment in which SES will operate in the future, and such assumptions may or may not prove to be correct. These forward-looking statements speak only as at the date of this presentation. Forward-looking statements contained in this presentation regarding past trends or activities should not be taken as a representation that such trends or activities will occur or continue in the future. SES, and its directors, officers and advisors do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

1) At constant FX (comparative figures restated to neutralise currency variations)
2) Excluding operating expenses/income recognised in relation to U.S. C-band repurposing and other significant special items (disclosed separately).
3) Adjusted Net Debt to Adjusted EBITDA, including 50% of €625M hybrid bond as debt
4) Financial outlook assumes a €/$ FX rate of €1 = $1.09, nominal satellite health, and nominal launch schedule.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240429774579/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye